But more traditional device makers seem uninterested in this means of stock market listing.
Discount pricing and poor first day defies the recent trend for floating device makers.
Non-Covid-19 medical device approvals tick up alongside the agency’s pandemic efforts.
Pinpointing new forms of the coronavirus could be vital, particularly if it mutates in response to vaccination, the company says.
It is vital that the first authorised at-home, non-prescription Covid-19 antigen test be used in the right way.
A new UK plan to use antigen tests for wide-scale screening for Covid-19 may not be the easy win the government is seeking.